Acco Brands (ACCO) – Cost Cutting Efforts Result in Above Expected 2Q EPS but Business Conditions Remain Challenging

Wednesday, July 29, 2020

ACCO Brands Corporation (ACCO)

Cost Cutting Efforts Result in Above Expected 2Q EPS but Business Conditions Remain Challenging

ACCO Brands Corporation designs, manufactures, sources, markets, and sells office products, academic supplies, and calendar products primarily in the United States, Canada, Northern Europe, Brazil, Australia, and Mexico. It operates through three segments: ACCO Brands North America, ACCO Brands EMEA, and ACCO Brands International. The company offers office products, such as stapling, binding and laminating equipment, and related consumable supplies, as well as shredders and whiteboards; and academic products, including notebooks, folders, decorative calendars, and stationery products. It also provides private label products, as well as business machine maintenance and repair services. The company offers its business, academic, and calendar product lines under the Artline, AT-A-GLANCE, Derwent, Esselte, Five Star, GBC, Hilroy, Leitz, Marbig, Mead, NOBO, Quartet, Rapid, Rexel, Swingline, Tilibra, Wilson Jones, and other brand names. In addition, it designs, sources, distributes, markets, and sells accessories for laptop and desktop computers, and tablets comprising security products; input devices, such as presenters, mice, and trackballs; ergonomic aids, including foot and wrist rests; docking stations; and other personal computers and tablet accessories under the Kensington, Microsaver, and ClickSafe brand names. The company sells its products to consumers and commercial end-users primarily through resellers, including traditional office supply resellers, wholesalers, mass merchandisers, and retailers, as well as directly to consumers through on-line and direct mail. ACCO Brands Corporation is headquartered in Lake Zurich, Illinois.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    2Q20 Results. Revenue of $366.9 million declined 29.3% y-o-y with comp sales off 28.3%. GAAP net income totaled $5.4 million, or $0.06 per share, compared to $35.9 million, or $0.35, last year. Adjusted net income was $11.6 million, or $0.12 per share, versus $36.3 million, or $0.36 per share, in 2Q19. Quarterly results were negatively impacted by the COVID crisis and $6.5 million of restructuring costs.. Results came in at the lower end of management’s guidance of a 25%-40% sales decline and above the guided adjusted EPS of a loss of $0.05 to a positive $0.07. We had forecast revenue at $363 million, net income of $0.02, and adjusted net income of $0.04.

    Cost Reductions. Savings from cost reductions reduced 2Q expenses by some $33 million, which drove the positive earnings in the face of the revenue decline. Further actions to focus the business on faster growing categories and channels will result in an expected additional …




    Click to get the full report

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Release – Sierra Metals Announces Restart Of Production At Its Cusi Silver Mine, Mexico

Sierra Metals Announces Restart Of Production At Its Cusi Silver Mine, Mexico

 

  • Production plans include recently announced high-grade silver discovery,

  • Silver expected to become a significant contributor to Company’s Revenue Mix


Toronto, ON – July 27, 2020 – Sierra Metals Inc. (TSX: SMT) (NYSE American: SMTS) (BVL: SMT) (“Sierra Metals” or the “Company”) announces that it has restarted operations and production at its Cusi Silver Mine in Mexico.  The Company has implemented a process at the mine to mitigate COVID-19 risk to employees at the site, and the surrounding communities, through a testing and quarantine methodology similar to the Company’s other operations. 

Luis Marchese, CEO of Sierra Metals, commented: “I am very pleased that we are restarting operations and production at Cusi.  The improved silver metal price provides for greater cash flow potential from Cusi, contributing to revenue for the Company. The management team expects to continue ramping ore throughput up to the targeted rate of 1,200 tonnes per day by the end of the year, and we have plans to update studies in the second half of the year for the next phase of Cusi.”

He added, “Mine development work in the past month has prepared zones for production, including part of the high-grade Northeast-Southwest silver discovery, announced recently in our press release of June 18, 2020.  The higher grades and wider zones of these structures are a source of further value creation for the company”.

The Cusi Mine had remained in care and maintenance since April 1, 2020, due to the government-mandated shutdown to contain the advancement of COVID-19. This care and maintenance period allowed the management team to complete an optimized review of the entire mine operation. These changes have included an updated interpretation of the geological system at the Santa Rosa de Lima structure from a stockwork tonnage system to a vein model system.  This change is expected to better control and improve head grades and reduce dilution. Mine development to bypass the previously announced area of subsidence and provide access to economic ore to provide feed for the mill has been advanced during this period. 

The Company is currently drilling from the surface targeting its recently announced discovery of a new high-grade silver zone in an area called Northeast – Southwest System of Epithermal Veins adjacent to the Santa Rosa de Lima zone, as mentioned in the press release dated June 18, 2020. Plans to drill an additional 1,000 meters to understand better the mineralization of the new zone are underway.

As of its last National Instrument 43-101 published report in Dec 2017, Cusi has over four million tonnes of mineral resources in the Measured and Indicated category, with an average silver grade of 224 grams per tonne providing for contained metal of 59 million silver ounces. Management expects to update the mineral resource estimates which will include the latest available drilling information. 

 

Silver production at Sierra Metals

Management expects that silver will become a significant contributor to the Company’s revenue mix with the restart of the Cusi Silver Mine when combined with the silver by-product credits from the Company’s Yauricocha and Bolivar Mines and the recent marked improvement in the silver metal price.

In 2019, Sierra Metals produced a total consolidated output of 3.4 million ounces of silver derived from its three mines.  The Yauricocha mine in Peru was the largest contributor to the silver production with 1.8 million ounces, followed by Cusi with a production of 936,000 ounces, and Bolivar in Mexico with 640,000 ounces. 

Copper is the most significant contributor to the Company’s consolidated sales revenues, followed by precious metals then zinc and lead. 

 

Quality Control

All technical data contained in this news release has been reviewed and approved by Americo Zuzunaga, FAusIMM CP (Mining Engineer) and Vice President of Corporate Planning is a Qualified Person and chartered professional qualifying as a Competent Person under the Joint Ore Reserves Committee (JORC) Australasian Code for Reporting of Exploration Results, Mineral Resources, and Ore Reserves.

Augusto Chung, FAusIMM CP (Metallurgist) and Consultant to Sierra Metals, is a Qualified Person and chartered professional qualifying as a Competent Person on metallurgical processes.

 

About Sierra Metals

Sierra Metals Inc. is a diversified Canadian mining company focused on the production and development of precious and base metals from its polymetallic Yauricocha Mine in Peru, and Bolivar and Cusi Mines in Mexico. The Company is focused on increasing production volume and growing mineral resources. Sierra Metals has recently had several new key discoveries and still has many more exciting brownfield exploration opportunities at all three Mines in Peru and Mexico that are within close proximity to the existing mines. Additionally, the Company also has large land packages at all three mines with several prospective regional targets providing longer-term exploration upside and mineral resource growth potential.

The Company’s Common Shares trade on the Bolsa de Valores de Lima and on the Toronto Stock Exchange under the symbol “SMT” and on the NYSE American Exchange under the symbol “SMTS”.

For further information regarding Sierra Metals, please visit www.sierrametals.com or contact:

 

Mike McAllister
V.P., Investor Relations
Sierra Metals Inc.
+1 (416) 366-7777
Email:
info@sierrametals.com

 

Luis Marchese
CEO

Sierra Metals Inc.

 

Continue to Follow, Like and Watch our progress:

Web: www.sierrametals.com | Twitter: sierrametals | Facebook: SierraMetalsInc | LinkedIn: Sierra Metals Inc
Instagramsierrametals

 

Forward-Looking Statements

This press release contains “forward-looking information” and “forward-looking statements” within the meaning of Canadian and U.S. securities laws (collectively, “forward-looking information“). Forward-looking information includes, but is not limited to, statements with respect to the date of the 2020 Shareholders’ Meeting and the anticipated filing of the Compensation Disclosure. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “expects”, “anticipates”, “plans”, “projects”, “estimates”, “assumes”, “intends”, “strategy”, “goals”, “objectives”, “potential” or variations thereof, or stating that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative of any of these terms and similar expressions) are not statements of historical fact and may be forward-looking information.

Forward-looking information is subject to a variety of risks and uncertainties, which could cause actual events or results to differ from those reflected in the forward-looking information, including, without limitation, the risks described under the heading “Risk Factors” in the Company’s annual information form dated March 30, 2020 for its fiscal year ended December 31, 2019 and other risks identified in the Company’s filings with Canadian securities regulators and the United States Securities and Exchange Commission, which filings are available at www.sedar.com and www.sec.gov, respectively.

The risk factors referred to above are not an exhaustive list of the factors that may affect any of the Company’s forward-looking information. Forward-looking information includes statements about the future and is inherently uncertain, and the Company’s actual achievements or other future events or conditions may differ materially from those reflected in the forward-looking information due to a variety of risks, uncertainties and other factors. The Company’s statements containing forward-looking information are based on the beliefs, expectations and opinions of management on the date the statements are made, and the Company does not assume any obligation to update such forward-looking information if circumstances or management’s beliefs, expectations or opinions should change, other than as required by applicable law. For the reasons set forth above, one should not place undue reliance on forward-looking information.

Is $40 the sweet spot for sweet crude?

OPEC Output Reductions Expire Soon – Members are Anxious to Open the Taps

West Texas Intermediate (WTI) crude oil prices have traded in a range of $40 to $80 per barrel (bbl) for the last several years.  Prices dropped below that range in April when the combination of pandemic fears and a price war between Saudi Arabia and Russia caused prices to drop sharply.  Since April, WTI oil prices have improved to a level near $40/bbl as economies have begun to reopen, and OPEC plus members reached an agreement to cut supply by 10%.  The oil future’s curve is flat, implying that investors believe the price of oil will stay near $40 per barrel.  Has $40/bbl, once considered the bottom end of the trading range, become the new normal?

The case against $40/bbl oil being the new norm and prices returning to higher levels

  • OPEC has regained its market dominance. After demonstrating its willingness to corral production cheaters by threatening to open the spigots, Saudi Arabia successfully negotiated a 10% output reduction among the OPEC plus members. By showing its dominant position, it has once again taken a leadership position that will help reduce the temptation for members to cheat and overproduce. 
  • Economies are improving due to governments’ stimuli and the hopes of a vaccine.  Governments have been aggressively pumping money into their economies to offset economic weakness caused by the pandemic.  The EU recently announced an $859 billion fund to prop up their economies while the United States is working on a $1 trillion, stage two stimulus package.  Several vaccines have entered the testing stage, giving hope to investors that the world economies could return to a more normal state shortly.
  • North America needs prices above $40/bbl to justify new drilling.  To obtain double-digit returns, most production areas need oil prices above $40/bbl.  When prices rose above $50/bbl, domestic producers responded by increasing drilling and made the United States the largest producer of oil.  However, when oil prices dropped below $40, drilling came to a virtual standstill.  U.S. producers are the producers on the margin who will determine the price of oil, and $40/bbl is not enough to satisfy U.S. producers.

 

The case for $40/bbl (or lower) being the new normal

  • The OPEC reduction expires soon.  Production cuts for May and June were extended through July.  OPEC members, however, are anxious to turn the spigots back on now that prices are above $40/bbl.  Importantly, not all members signed on to the extension citing economic difficulties as a reason they could not participate.  A further extension is far from being certain, meaning a drop in oil prices below $40/bbl is a possibility.
  • The effects of the pandemic could last years.  Government stimulus has propped up economies giving hope that things will return to normal when a vaccine is available.  However, that may not be the case.  The secondary effects of the pandemic could last for years.  Governments that are saddled with debt may need to cut back future spending.  Unemployment is unlikely to return to pre-pandemic levels as economies shift to a new way of life.  Consumers that have run through savings will be reluctant to spend.
  • Shale production continues to improve.  Domestic producers may be the producers on margin and need oil price north of $40/bbl.  However, that is changing.  Technological improvements continue.  Producers continue to refine the drilling process experimenting with differing fracking laterals and fracking components.  The result is a continuing declining cost of production that makes drilling at lower prices feasible.  Today, few wells earn adequate returns at $40/bbl.  But soon, wells may earn attractive returns at prices in the thirties.

There are many unknowns facing the energy industry.  When will demand come back?  Will OPEC be able to remain united in its efforts to curb production? Will production cost reductions continue?  The fact that the oil future’s curve is flat at $40/bbl may be a sign that there is uncertainty in the market more than a belief that prices will hold constant.  There are good arguments for oil prices, both going up and going down.  But then again, that usually is the case.

 

Suggested Reading:

Exploration and Production Second Quarter Review and Outlook

Is M & A Picking up in the Energy Sector?

Ruling Out Nuclear Energy Now Could Be a Mistake

 

Enjoy Premium Channelchek Content at No Cost

 

Each event in our popular Virtual Road Shows Series has maximum capacity of 100 investors online. To take part, listen to and perhaps get your questions answered, see which virtual investor meeting intrigues you here.

 

Sources

https://qz.com/1880939/why-oil-prices-have-stalled/?utm_source=YPL&yptr=yahoo, Tim McDonnell, Quartz, July 15, 2020

 https://finance.yahoo.com/news/oil-steady-vaccine-news-counters-020853525.html, Laila Kearney, Reuters, July 20, 2020

https://www.cnbc.com/2018/12/19/the-permian-basin-has-a-new-problem-40-crude-oil-price.html, Tom DiChristopher, CNBC, December 19, 2018

https://www.cnn.com/2020/06/06/investing/opec-oil-opec-production-cuts/index.html, Shannon Lee, CNN Business, June 6, 2020

Release – Helix BioPharma Virtual Town Hall 2020-07-29

 

Virtual Town Hall
Wednesday, July 29nd 2020 @ 12:00pm EST

 

You are cordially invited to attend Helix BioPharma presenting at the AlphaBronze Virtual Town Hall, taking place on Wednesday, July 29nd at 12:00pm EST

 

Helix BioPharma – Town Hall Agenda

CEO Presentation – 10 to 15 minutes

Follow-up Q&A – 10 to 15 minutes

 

REGISTER

https://zoom.us/webinar/register/WN_0tdX0OQrTuS_gJCk53zVTQ

 

After registering, you will receive a confirmation email containing information about joining the webinar.

For more information on Helix BioPharma: https://www.helixbiopharma.com

 

Speaker – CEO Dr. Heman Chao

Dr. Chao will give an overview of the Company, its Lung Cancer and Pancreatic Cancer Clinical programs and upcoming milestones. Dr. Chao will respond to Investors questions thereafter.

Helix BioPharma Corp. (TSX: HBP) is a clinical-stage biotech, focused on immuno-oncology. The biotech is specializing in the field of cancer therapy and actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies, DOS47. Its patented oncology platform technology – DOS47 – offers a new and revolutionary approach to the debilitation and destruction of cancer cells by modulating the tumor microenvironment.

Founded in 1995, Helix BioPharma is based in Toronto. Helix Clinical Trials and programs’ focus are on Lung and Pancreatic cancer. In December 2019, it started patient’s enrollment for its L-DOS47 Phase lb/ll Pancreatic Cancer Clinical Study. Pancreatic cancer is an important cause of cancer death in the US – with few treatment options.

1-800-Flowers.com (FLWS) – Puts The Acquisition To Bed

Tuesday, July 28, 2020

1-800-Flowers.com (FLWS)

Puts The Acquisition To Bed

1-800-FLOWERS.COM, Inc. is the leading provider of gourmet and floral gifts for all occasions. For nearly 40 years, 1-800-FLOWERS® has been helping deliver smiles for customers with gifts for every occasion, including fresh flowers, premium, gift-quality fruits, and other gourmet items from Harry & David®, popcorn and specialty treats from The Popcorn Factory®; cookies and baked gifts from Cheryl’s®; premium chocolates and confections from Fannie May®; gift baskets and towers from 1-800-Baskets.com®; premium English muffins and other breakfast treats from Wolferman’s; carved fresh fruit arrangements from FruitBouquets.com; and top quality steaks and chops from Stock Yards®. The Company’s BloomNet® international floral wire service provides a broad range of quality products and value-added services designed to help professional florists grow their businesses profitably.

Michael Kupinski, Director of Research, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Back on track.The company settles its issues with Bed, Bath & Beyond regarding the acquisition of PersonalizationMall.com and amends the purchase price to $245 million from $252 million. We believe that the new price largely adjusts for legal fees. Closing date is set for August 3rd.

    Acquisition viewed favorably. The stall in the closing date allowed 1800Flowers to substantially improve its financial position, given strong growth in e-commerce sales, particularly for Harry & David. While PersonalizationMall.com was closed for a period of time due to …




    Click to get the full report.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Will 2020 Go Down as the Year of the SPAC?

Special Purpose Acquisition Corporations (SPAC) Attracting Investors

“So, we’re looking to marry a unicorn. So we’re prettying ourselves up for the most attractive possible partner…” – Bill Ackman, July 22, 2020

 

On July 21, Pershing Square Tontine Holdings raised $4 billion by offering 200 million units at $20 per share in the largest IPO of a special purpose acquisition corporation (SPAC). Several high-profile companies, including Nikola, Fisker, and DraftKings, agreed to merge with a SPAC as a means of going public instead of pursuing their own initial public offerings. According to SPACInsider, 59 SPAC IPOs raised $13.6 billion in 2019 with an average IPO size of $230.5 million. In 2020, 50 SPACs have gone public that raised $19.0 billion with an average IPO size of $380.1 million. During the period 2009 through 2020, there have been 274 IPOs that raised $65.7 billion.

What is a SPAC?

A special purpose acquisition corporation (SPAC), also known as a blank check company, is generally sponsored by an investor (i.e., Pershing Square Capital Management) and/or a management team and raises capital in an initial public offering (IPO) with the intention of completing an unidentified acquisition that meets the SPAC’s investment objective. The IPO proceeds are held in trust that can only be accessed to consummate an acquisition. If the SPAC does not complete an acquisition within a specified time frame, it must liquidate and return the trust proceeds to its stockholders. Once the SPAC finds a company to acquire, investors have the choice of staying invested in the SPAC or redeeming their shares, if they do not like the transaction, for the amount for which they were acquired.

The Rationale

SPACs offer an alternative to a traditional initial public offering as a way for companies to go public. For some companies, it may be difficult to go public due to size, lack of investor interest, or a challenging IPO environment. Some companies in a “hot” sector may chafe at the prospect of their stock price taking off after a traditional initial public offering meaning that they might have left too much money on the table. For some, merging with a SPAC may offer a less costly and/or burdensome means of going public. Importantly, SPACs offer an alternative for private equity and/or venture capital firms to exit their investments. Because sponsors include providers of private equity, some may view it as a sign of asset managers’ growing influence in the capital markets.

The Take-Away

Judging from the data below provided by SPACInsider, the number of special purpose acquisition corporation IPOs accelerated in 2017.

Source: SPACInsider and Noble Capital Markets

With no shortage of private companies capitalized by private equity and venture capital firms, coupled with well-recognized sponsors like Apollo Global Management and Pershing Square Capital Management launching successful SPAC IPOs, it is likely the trend may continue.

 

Suggested Reading:

Will Broadcast Mergers and Acquisitions Surge?

Will there be an Explosion of New Acquisitions?

Can the Market Continue to Defy Gravity?

Enjoy Premium Channelchek Content at No Cost

 

Each event in our popular Virtual Road Shows Series has maximum capacity of 100 investors online. To take part, listen to and perhaps get your questions answered, see which virtual investor meeting intrigues you  here.

 

Sources:

Bill Ackman and Tontine Holdings Rewrite the Terms for SPACs, CNBC, Kenneth Squire, July 22, 2020.

Nikola and DraftKings Stock Started As ‘SPACs.’ What Investors Need to Know, Barron’s, June 22, 2020.

SPAC IPO Transactions – Summary by Year, SPACInsider, July 2020.

Go SPAC Yourself, Techcrunch, Alex Wilhelm, July 22, 2020.

Bill Ackman’s blank-check acquisition company to begin trading on Wednesday after Raising up to $4 billion, Markets Insider, Ben Winck, July 21, 2020.

SPAC-and-Span: A Clean Exit?, Harvard Law School Forum on Corporate Governance, Carol Anne Huff, Daniel Wolf, Kirkland Ellis, July 9, 2015.

Electric Car Maker Fisker to Go Public Through SPAC Deal at $2.9 Billion Valuation, Reuters, Ben Klayman, July 13, 2020.

Big Blank Checks, The New York Times, Dealbook Newsletter, July 14, 2020.

Ackman-backed Blank Check Company’s Units Rise in NYSE Debut, Reuters, C. Nivedita and Joshua Franklin, July 22, 2020.

Trading vs Investing vs Tomorrow

Why Robinhood Traders May Never Find the Next Apple

“I encourage people to educate themselves, but short-term
trading is more risky than long-term investing and I do worry about this risk
investors take…”
Jay Clayton, SEC chairman, July 22, 2020

 

Are you growing weary of officials at different levels of government telling us how
they think we should protect ourselves? In the first half of 2020, it seems a record number of authorities, at times, openly ignoring their own advice, told us what’s “safe” and what’s “unsafe.” The advice is all worth considering before determining if you agree or not, but when it involves risk tolerance, that’s a very personal choice. So, if you disagree with the advice, it may be that you know what’s better for you when it comes to your own risk/reward tolerance. One recent warning that is worth considering occurred on July 22 on CNBC Squawk box. The Chairman of the U.S. Securities and Exchange Commission discussed what he thought was risky behavior, and the precautions retail investors can take to reduce their risk. What was said involves self-directed investors’ choice of stocks. The SEC does restrict the sale of unregistered securities to accredited investors, but commenting on investor’s valuation methods and holding periods seems barely within the purview of the SEC’s Congressional mandate.

The SEC’s stated mission is threefold:

  • Protect investors
  • Maintain fair, orderly and efficient markets
  • Facilitate capital formation.

Based on the interview, it seems the activities of the latest crop of market participants are causing the SEC chair, Jay Clayton, to sprout some gray hairs. He’s concerned that individual investors are using assets for risky, short-term trades.  These are primarily younger market participants, taking full advantage of free online trades. Recently, according to him, they’ve been causing the price of “certain stocks” to skyrocket. If his concerns are accurate, the SEC may further address it as part of one of the three stated roles they serve. 

Protect Investors

The primary means the SEC “protects” investors is their disclosure rules and transparency requirements. These regs are designed so all investors, large institutions, or dabbling individuals will have access to basic facts about an investment prior to deciding whether or not they should transact. This is why the SEC requires public companies to regularly report specific financial and other pertinent information. The stipulation provides a base of knowledge for all investors so they may use it to judge for themselves whether to buy, sell, hold, or avoid an offering. It’s through the scheduled flow of timely, comprehensive, and accurate information that investors have a uniform basis for judgement.  

Chairman Clayton seems to have concerns beyond company reporting requirements. His worry is with the investor side, not the issuer side. Clayton specifically expressed concerns for smaller investors with very short holding periods. His words during the July 22nd interview are:

“What we are seeing is significant inflows from retail investors, and they have the hallmarks of short-term inflows. And does that concern me? Sure. Because that’s more trading than investing…”

He continued by expressing:

“Short-term trading is much more risky than long-term
investing, and so I do worry.”

There will always be investors and traders looking to beat the market. This reality guarantees that there will always be people who find different methods than those that came before. Certain “styles” will seem to some to be unconventional, others risky, and to some just reckless. There seems to be a new “style” every few years. SOES trading, Japanese pairs, Tech funds, Bitcoin, Index funds, Leveraged CMOs, etc. Some of these blew up on participants while they were involved, others blew up later, and some methods, like many of today’s Robinhood traders, Bitcoin investors, and some Index fund buyers are still rewarding participants.

Should the Chairman of the SEC allow himself to be openly concerned for those involved so as to  “protect investors?” Probably not under this part of their mandate. Should he be concerned because it impacts the commission’s second mission; to maintain “fair, orderly and efficient markets?” Let’s explore further.

Maintain Fair, Orderly and Efficient Markets

The SEC oversees securities broker/dealers, exchanges, investment advisors, and mutual funds. A primary concern is “fair” dealing, protecting against fraud, and disclosure of important market-related information to investors. With this, they make rules, after all, fairness amongst all involved dictates that regulators act with clear guidelines, not arbitrarily. 

“Orderly” and “efficient” speaks to the manner and speed in which the commission handles all of the items on its plate. The markets are continually coming up with new products.  Over time each of the new products usually has variants. The variants eventually have offshoots. The broad spectrum of investment options the SEC oversees doesn’t just grow, it compounds. Similar to how investors are creative in their methods, those that serve buy and sell-side players also are inventive. Newly engineered investments require review. The SEC expedites these reviews for the benefit of all. An easy to understand example is their review of the Spyder ETF, which was a unique security in the 1990s. This product was quickly mimicked and also expanded to include many other specific indexes. After the SEC became accustomed to the product and quickly approving other transparent ETFs, they had to review and make determinations on novel ETFs such as the actively managed, non-transparent ETF. The SEC knows the markets work best if there are no bottlenecks to the approval of newly securitized offerings or exchange tools, but they must all be reviewed.

Are no-transaction-fee online trades a new invention. No. They seem to be an evolution of lower and lower fees that began since brokerage commissions became competitive in May of 1975.  The same (or better) service has been offered at lower and lower prices since then. Do the no commission brokers impact the market? Not in as large a way as “program trading” did when it first began or the introduction of computers or the reduction of brokerage commissions from $100 to $10 by Charles Schwab and others. So this is not of much consequence to the SEC. It provides even more access to the markets.

Although he did not name companies, Clayton spoke of stocks far exceeding normal valuations, which make them expensive by historical standards. He’s concerned the stocks may be rising more on emotion than prudent valuation processes. In his discussion, Clayton added that the SEC had issued guidance to brokers and investment advisors on how to give individuals proper warning about the risks they face when allocating capital in select equities. He did not suggest which equities, it is presumed he was thinking about companies like Tesla, which is up 240% YTD and 521% over the past 12 months. Tesla is the 10th most popular stock on Robinhood. Many renowned investors are short this stock (TSLA), in fact current short interest in TSLA is $28.5 billion. So this is a very real battle of well-known investors with huge short positions and tens-of-thousands of Robinhood accounts impacting price movement.

The guidance he suggested is a further explanation of risks to investors. This, of course, is within the mandate of the SEC, and is fair in that it may help the understanding of risk, while not setting guidelines that would directly impact companies or individuals.

Facilitate Capital Formation

When Congress included the consideration of “capital formation” in the SEC’s mandate, it did not define the term. However, it is not an unfamiliar concept. It is generally understood that capital formation is a macro benchmark that measures changes in productive capital available in the economy. This includes enhanced infrastructure as the economic base of capital formation. It is however, most often defined as the ability for entities to raise funds. If funds are more available for the same or an increase in purposes, this constitutes capital formation. To reiterate, it is not the act of raising capital as much as it is the availability of capital that is capital formation.

Surely individuals trading in their Interactive Brokers, Robinhood, or All of Us accounts are not creating more capital. At the same time, it is not hindering capital formation. So, as it relates to the SEC mandate, this is not adding to why SEC Chairman Jay Clayton is so concerned.

How to “Protect Ourselves”

Referring to the inflows of assets into accounts from investors and the holding period, Clayton said this during the CNBC interview:

“Here at the SEC, when we think about that investor, we think about someone who’s investing for the long term: investing over time, doing it on a monthly basis…”

As a result of the concern very short holding periods (trading not investing), the SEC has issued guidance to brokers and investment advisors on how to give individuals proper warning about the risks they face when allocating capital in select equities, and statistical risk to overtrading. The active trading language is not new; the language on specific equities is not defined but presumed to mean so-called “Robinhood” stocks.

“I hope people are heeding that,” he said.

The age group most associated with online trading apps are “the millennials.” This generation takes a lot of criticism from the generations that are older than them. Their sanity is again questioned as they trade shares of stocks under $5, or load up on bankrupt companies like Hertz, and JC Penney, and when the online traders drive the price up on Tesla while Wall St. giants are short the stock. What is the right way and wrong way to invest is measured by results.  Today’s lack of transaction fees eliminates what had been a very large drag on results in the past. Perhaps it is the veterans relying on past performance to indicate future results that have it wrong. Time will tell.

These disagreements as to value are what makes markets. Investing goes through regular incarnations and reinventions. The use of technology has provided an environment where one need not be a Wall Street professional to have access to information and top execution. This latest generation that is comfortable with technology now finds themselves with discretionary investment accounts. They will make good trades and bad trades and we’ll all learn from each other. 

Paul Hoffman

Managing Editor

 

Suggested Reading:

Investment Portfolios are Checked Twice as Often by Millennials

The Supply of Cash and Stock Prices

Has Robinhood, the Online Brokerage Disruptor, Been Disrupted?

 

Enjoy Premium
Channelchek Content
 at No Cost

Each event in our popular Virtual Road Shows Series has maximum capacity of 100 investors online. To take part, listen to and perhaps get your questions answered, see which virtual investor meeting intrigues you  here.

 

Sources:

The Role of the SEC

The New Age of Investor Relations

SEC Chief Worries About Retail Investors Trying to Get Rich Quick

SEC Chair Speech

The
Genesis of Discount Brokerage

Bets Against Telsa Stock Approach $30b

SEC Chair Clayton on Squawkbox Transcript

SEC Investor Objectives

Kratos Defense & Security (KTOS) – Skyborg Award

Friday, July 24, 2020

Kratos Defense & Security (KTOS)

Skyborg Award

Kratos Defense & Security Solutions is a National Security technology provider with proprietary expertise in the area of unmanned aerial vehicles, electronics for missile defense systems, electronic warfare systems, satellite control and management systems and support services for emerging naval weapon systems. Commercial and state and local government revenues are about 25% of the total and comprise primarily of critical infrastructure monitoring and protection systems.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Award. Last night, the Air Force announced Kratos had been awarded a position in support of the Skyborg Vanguard Program. Skyborg is an autonomous attritable aircraft capable of achieving a diverse set of missions to generate massed combat power, including manned/unmanned teaming. Last night’s announcement is a key milestone for Kratos in our view.

    The Details. Kratos, along with Boeing, General Atomics , and Northrop Grumman have each been awarded indefinite-delivery/indefinite-quantity contracts with a shared ceiling of $400 million for all subsequent competitively selected delivery orders in support of the Skyborg program. This was a competitive acquisition with …



    Click to get the full report.

This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

PSCs Can Function Like Embryonic Stem Cells

Are Pluripotent Stem Cell Based Therapies Close to Market?

The history of deriving embryonic stem cells from mice goes back to its discovery in 1981. This was followed by a decade of research on mouse stem cell biology, which led scientists to find a method to derive stem cells from human embryos. In 1998 they developed a method to grow them in a laboratory setting. This was followed by another breakthrough in 2006; the identification of conditions allowing some specialized adult cells to be genetically reprogrammed to assume a stem cell-like state. These cells are called induced pluripotent stem cells (iPSCs). Shinya Yamanaka (Kyoto University, Japan and Gladstone Institutes, USA) and John Gurdon (Gurdon Institute, Cambridge, UK) received the Nobel Prize for Physiology or Medicine for the discovery of mature cells reprogrammed into a pluripotent state in 2012.

Many discoveries and milestones in the field ushered in a transition from fundamental research to pre-clinical research, and then to clinical trials. The history of stem cell research is highlighted in Exhibit 1. PSCs entered into the clinic first for the treatment of advanced macular degeneration in 2017 (Mandai et al. 2017).

Exhibit 1. The history of stem cell research

Source: Stem Cell Rev and Rep (2020) 16:3 –32

PSCs can function like embryonic stem (ES) cells and have the ability to differentiate or develop into a variety of specific cell types in the body, such as liver cells, muscle cells, blood cells (Exhibit 2). Stem-cell-based therapeutics is widely considered as a promising and exciting arena in medicine attributed to their capability of regenerating and repairing damaged tissues.

Exhibit 2. Stem cells can differentiate into any type of
cell in the body

 

Source: SM. Afify et al. Cancers 2019, 11, 345

The transplantation into patients presents unique safety risks of human PSC (hPSC)-derived cell therapies. The major risks include i) hPSC differentiation yielding to a heterogeneous cell population, ii) residual undifferentiated hPSCs (10,000 or even fewer) forming a teratoma (a tumor made up of several different types of tissue, such as hair, muscle, teeth, or bone).

Exhibit 3. Safety risks of pluripotent cell-based
therapies

Source: RM. Martin ET AL. Nature Communications, (2020) 11:2713

Many hurdles and limitations in the production of clinical-grade embryonic stem cells (ESC) and iPSC derivatives have since been overcome. These cells can now be expanded in scalable suspension culture, a targeted, robust, and efficient differentiation of human ESCs and iPSCs can be achieved via inhibition and activation of molecular differentiation pathways.

Over the past 20 years, significant developmental milestones have driven basic, translational, and clinical advances in the fields of stem cells and regenerative medicine. Over the past decade, human pluripotent stem cell (hPSC)- derived cell therapies have been assessed in over 30 ongoing or completed clinical trials for various indications -including spinal cord injury, macular degeneration, and type 1 diabetes. Due to the immune privilege, the vast majority of the current clinical trials on transplantation of PSC-based cell products aim to treat macular degeneration. The eye is an “immune privileged” site. This phrase was defined by Peter Medawar and colleagues in the 1940s following the skin allografts placed within the anterior chamber of the eye surviving indefinitely, while their rapid rejection in other tissues such as the skin. The ocular microenvironment is highly anti-inflammatory. Multiple factors -such as proteins, neuropeptides, and biochemicals- modify the behavior, differentiation, and survival of immune cells within the ocular microenvironment promoting an anti-inflammatory, immune response, and induction of immune tolerance, which protects the eye from the irreversible collateral damage of inflammation that can lead to blindness.

Cellular therapies based on iPSCs are considered innovative but complex therapeutic concepts. The human pluripotent stem cell (hPSC)- derived cell therapies have rapidly expanded potential as therapeutics; however, they continue to carry safety risks. The scientific community has teamed up for the development of therapeutic applications and cellular products. The identification of the right patient population/indication and discovery of the optimum delivery route are crucial components for successful hPSC-derived cell therapy. Considering the scientific advancement in the genome editing approaches to the platform’s engineering, imaging, and other research and clinical tools, it may be a matter of time for hPSC-derived cell therapies to become a reality and lead to another breakthrough in medicine.

 

Suggested:

Dyadic C-Suite Interview

Neovasc C-Suite Interview

Therapeutics MD Research note

Enjoy the
Benefits of 
Premium Channelchek
Content
 at No
Cost

 

Each event in our popular Virtual Road Shows Series has maximum capacity of 100 investors online. To take part, listen to and perhaps get your questions answered, see which virtual investor meeting intrigues you  here.

DLH (DLHC) – Virtual Non-Deal Road Show

Friday, July 24, 2020


DLH Holdings Corp. (DLHC)

Virtual Non-Deal Road Show

DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of veteran affairs, Department of health and human services, Department of Defense and other government agencies. It operates primarily through prime contracts and also derives its revenue from agencies of the federal government, primarily as a prime contractor but also as a subcontractor to other Federal prime contractors.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    VNDRS. On Wednesday, Noble Capital hosted a virtual non-deal road show with DLH CEO Zachary Parker and CFO Kathryn JohnBull. Management showcased the favorable market outlook, especially related to COVID-19 opportunities, and DLH’s strong market position. A link should be available shortly at www.channelchek.com.

    DLH Infinibyte Cloud and FedRAMP. DLH Infinibyte Cloud solution-a cloud based Platform-as-a-Service for massive data analytics-is expected to receive full FedRAMP certification by the end of 2020. We think the potential here is currently understated. Amazon’s AWS and Microsoft’s Azure cloud-based storage platforms are used by thousands of government agencies. DLH’s Infinibyte positions the Company to …



    Click to get the full report.

This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Is M and A Picking Up in The Energy Sector?

Chevron Announces the Acquisition of Noble Energy
Will Other Oil and Gas Producers Follow?

On July 20, Chevron Corporation announced it would buy oil and gas producer Noble Energy Inc for $5 billion in stock.  Noble is a highly leveraged company with $8 billion of debt that will be assumed by Chevron.  The shares of Noble have been weak this year along with most leveraged energy companies, having begun the year with a market capitalization near $12 billion.  Noble’s assets will expand Chevron’s shale presence in Colorado and the Permian Basin.  Chevron was close to adding Permian Basin assets last year when it attempted to acquire Anadarko Petroleum.  The Noble acquisition is the largest energy acquisition to be announced in 2020.  As is usually the case, the acquisition begs the questions, “will the acquisition lead to other acquisitions?”

Why Merger Activity Picks Up

The energy industry has always been cyclical, and we remain in the down part of the cycle.  When energy prices are high, managements often take on additional leverage to expand drilling efforts because returns look so attractive.  When prices drop like we have seen this year, the return on those assets is not as attractive, but management is still saddled with the debt they have taken on.  Selling assets is always an option, but there are few takers when everyone is in the process of cutting back, and asset returns are low.  Often, smaller, leveraged energy companies are forced to issue stock at low prices or face the risk of being forced into bankruptcy.

Another option is to sell the entire company.  It is not unusual to see a pickup in merger activity when energy prices have fallen.  Major oil companies, which built up large cash positions during the upcycle, are more than willing to pounce on companies during times of desperation.  Of course, the major oils are not going to waste their time on small acquisitions that will not have an impact on top-line growth.  They want mid-sized companies that will take them into new areas of production, which is why a combination like Chevron and Noble makes sense – a major oil buying a mid-sized energy company.

Expectations for the Months Ahead

S&P Global Market Intelligence concludes that the biggest oil deals have come following oil price crashes.  They point out that since 1995, more than 50 deals have been completed, valued at over $10 billion.

 

So, will Chevron’s acquisition of Noble push the other major oils to follow suit?  Probably not.  In some ways, Chevron was still playing catch up the merger activity completed by the other majors in recent years.  The $13 billion acquisition of Noble still pales in comparison to the $33 billion attempted acquisition of Anadarko last year.  In fact, it would not be surprising for Chevron to announce additional acquisitions, albeit once it has had the time to digest the Noble acquisition.  In our opinion, the events surrounding the acquisition are unique in that Chevron was a uniquely motivated buyer seeking to make a major splash to expand in the Permian Basin.

Take-Away

Chevron’s acquisition of Noble probably speaks more to the validity of the Permian Basin than it does to the energy consolidation environment.  Recall that the Permian Basin has become one of the world’s most prolific oil fields following years of falling operating costs due to improved drilling technology.  That came to a bit of a halt this spring when a global economic downturn drove down oil demand forecasts, and an oil price war between Saudi Arabia and Russia flooded the market with additional supply.  With oil prices dropping into the twenties, it became difficult for energy companies to justify drilling new wells in the Permian Basin.  Most experts think producers need an oil price in the forties to justify drilling in the Permian.  Although oil prices have risen back into the forties, the threat of further global weakness or the ending of a contentious detente between Saudi Arabia could mean lower oil prices. Chevron’s acquisition, then, is a sign that they believe in the long-term viability of drilling in the Permian Basin.

Suggested:

Energy Industry Report – Second Quarter Review and Outlook

Will There be an Explosion in New Acquisitions

C-Suite Interview, Indonesia Energy

Enjoy the
Benefits of 
Premium Channelchek Content at No Cost

Each event in our popular Virtual Road Shows Series has maximum capacity of 100 investors online. To take part, listen to and perhaps get your questions answered, see which virtual investor meeting intrigues you 
here.

 

Sources:

https://finance.yahoo.com/news/chevron-buy-noble-energy-5-111125456.html, Jennifer Hiller, Reuters, July 20, 2020

https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/consolidation-coming-oil-companies-set-to-party-like-it-s-1999-58753567, S&P Global Market Intelligence, May 28, 2020

https://www.bizjournals.com/houston/news/2020/02/06/energy-analyst-expects-consolidation-deals-in-2020.html, Joshua Mann, Houston Business Journal, February 6, 2020

https://seekingalpha.com/article/4358468-energy-stocks-breakout-following-healthy-consolidation-just-global-oil-inventories-start-to, Seeking Alpha, Juley 14, 2020

https://www.reuters.com/article/us-global-oil-shale-bust-insight/oil-in-the-age-of-coronavirus-a-u-s-shale-bust-like-no-other-idUSKCN21X0HC, Jennifer Hiller, Liz Hampton, Reuters, April 15, 2020

Kratos Defense & Security (KTOS) – Acquisition Rumors Drive Shares Up 11 Percent

Thursday, July 23, 2020

Kratos Defense & Security (KTOS)

Acquisition Rumors Drive Shares Up 11%

Kratos Defense & Security Solutions is a National Security technology provider with proprietary expertise in the area of unmanned aerial vehicles, electronics for missile defense systems, electronic warfare systems, satellite control and management systems and support services for emerging naval weapon systems. Commercial and state and local government revenues are about 25% of the total and comprise primarily of critical infrastructure monitoring and protection systems.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Acquisition Rumors. Yesterday, various news sources discussed Lockheed Martin as a potential acquiror of Kratos. According to the reports, Lockheed Martin’s new CEO James Taicliet said in a Bloomberg interview published after the company’s earnings call that the company’s focus for M&A will be on “pure-play defense,” although the collapse in air travel has him “shying away” from any expansion into commercial aerospace, Dealreporter said. Back in mid-2019, the news service previously said Lockheed “could be a natural suitor for companies like Mercury Systems (MRCY) or Kratos Defense & Security Solutions (KTOS),” the report noted, adding that based on Taicliet’s comments that Kratos “may be the more likely of the two.”

    Our Thoughts. Kratos has long been the subject of acquisition rumors and we do expect the long-term outcome for the Company is to be acquired by one of the Primes. A year ago, KTOS shares were above $24. Today, awards are closer but the stock is only at $17.85. We think management would need to see a price in excess of …



    Click to get the full report.

This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Genprex (GNPX) – NIH Grant Provides Validation for Diabetes Program

Wednesday, July 22, 2020

Genprex Inc.(GNPX)

NIH Grant Provides Validation for Diabetes Program

Genprex Inc is a U.S.-based clinical-stage gene therapy company. It is engaged in developing a new approach to treating cancer based on its novel proprietary technology platform, including initial product candidate, Oncoprex immunogene therapy. Oncoprex, which has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis in cancer cells and modulates the immune response against cancer cells.

Ahu Demir, Ph. D., Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Awarded an NIH Grant. Yesterday, Genprex (GNPX) announced that a grant of $2.59 million awarded to the company by the National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases. This grant will fund the ongoing preclinical research for proof-of-principle studies in preparation for human gene therapy clinical trials of GPX-002 in type 1 diabetes.

    Diverse portfolio with large market potential. Genprex’s lead drug candidate Oncoprex is currently being evaluated in combination with erlotinib for the treatment of non-small cell lung cancer (NSCLC) in Phase 2 clinical study. The company plans to assess Oncoprex in combination with Tagrisso and Keytruda, the trials are expected to commence in the next …



    Click to get the full report.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.